Summary
A VACCINE that would protect against a bird flu pandemic has been approved for sale in the EU.
The ruling from the European Medicines Agency will allow the British pharmaceutical giant GlaxoSmithkline to sell Prepandrix, which targets the H5N1 virus, in all 27 EU member states.See the full content of this document
Extract
Bird Flu Vaccine Gets Eu Backing
Glaxo, which has spent [pounds]1billio...
See the full content of this document
Sponsored links
